Stem cell infusions put to the test against a tough transplant complication
Disease control
Not yet recruiting
Researchers are testing whether infusions of bone marrow-derived mesenchymal stem cells, called MesenCell, are safe for adults with moderate or severe chronic graft-versus-host disease that has not responded to steroids and other standard treatments. The trial enrolls up to 20 pe…
Phase 1 • Sponsor: Pontifícia Universidade Católica do Paraná • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC